Metrics to compare | SILV | Peers Peers - average of corresponding metrics from companies closely matching SILV: CENTRALPHL, SILCOPHL, ORIONPHARM, IBP, TECHNODRUG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSILVPeersSector |
|---|---|---|---|---|
P/E Ratio | −13.4x | 12.6x | −0.4x | |
PEG Ratio | 0.78 | −1.28 | 0.00 | |
Price/Book | 1.0x | 1.4x | 2.6x | |
Price / LTM Sales | 6.3x | 2.1x | 3.1x | |
Upside (Analyst Target) | - | 32.0% | 48.9% | |
Fair Value Upside | Unlock | 12.3% | 6.2% | Unlock |
Silva Pharmaceuticals Limited engages in manufacturing and marketing of pharmaceuticals finished products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, antihistamine, anti-spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in therapeutic areas, such as anemias and other blood disorders, central nervous system, gastro- intestinal system, nutrition, anti-infectives, disinfectant, musculoskeletal and joint disease, respiratory system, cardiovascular system, endocrine system, and natural sweeteners. The company was incorporated in 2001 and is headquartered in Dhaka, Bangladesh.